TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
PRME

Prime Medicine, Inc.

Healthcare · Biotechnology

3.20$ +2.2% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

Prime Medicine, Inc. (PRME) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -163 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow PRME
Line item 2019 2020 2021 2022 2023 2024 2025
-1.3 -5.5 -34 -132 -165 -123 -163
0.0 0.0 0.6 2.2 4.7 6.1 5.4
0.4 1.7 6.5 14 26 29
2.1 -2.3 100 5.5
0.5 0.2 31 -35 2.6 31 -5.3
0.6 0.6 4.2 16 8.7 7.3 4.5
-1.1 -1.1 -74 -47 19 68 -109
181
10.0 35 269 181 0.7 196 152
8.6 28 162 2.6 -146 141 -120
-1.3 -6.2 -38 -148 -174 -130 -167

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?